PMID- 15951008 OWN - NLM STAT- MEDLINE DCOM- 20050926 LR - 20131121 IS - 0091-3057 (Print) IS - 0091-3057 (Linking) VI - 81 IP - 3 DP - 2005 Jul TI - MDMA (ecstasy) effects in pubescent rats: Males are more sensitive than females. PG - 635-44 AB - In Experiment 1, we assessed the effects of 3,4-methylenedioxymethamphetamine (MDMA) on locomotor activity in pubescent male and female Long-Evans rats. Thirty-nine day old rats were injected ip with 10 mg/kg of MDMA (ambient temperature 25 degrees C) three times at 2 h intervals. Initially, females showed greater locomotor activation by the drug than males, however after the second injection, males showed greater hyperlocomotion. After the third injection, 3 of 10 females and all of the males died. In the surviving females, we observed serotonin depletion in cortex and hippocampus, but catecholaminergic markers were unaltered. In Experiment 2, male and female rats were repeatedly injected with saline or 2, 5 or 10 mg/kg MDMA and body temperature was measured (ambient temperature 21.5 degrees C). After the third injection of 10 mg/kg MDMA, the MDMA-induced hyperthermia was greater in males than in females (about +0.8 degrees C); at the lower dose, no difference was observed. Probably because of the lower ambient temperature, only 1 female and 2 males succumbed to the MDMA treatment, and MDMA induced less serotonin depletion than in the first experiment, with no difference between females and males. Thus, pubescent males appear to be more sensitive than females to locomotor and hyperpyretic effects of MDMA. This sex-dependent effect, which is at variance with previously reported dimorphisms in psychostimulant effects, is discussed in terms of possible differences in dopamine D1 and D2 receptors at pubescence, or other factors related to drug metabolism. FAU - Koenig, Julie AU - Koenig J AD - Laboratoire de Neurosciences Comportementales et Cognitives, UMR 7521 CNRS-Universite Louis Pasteur, IFR 37 Neurosciences, GDR CNRS 2905, 12 rue Goethe, F-67000 Strasbourg, France. FAU - Lazarus, Christine AU - Lazarus C FAU - Jeltsch, Helene AU - Jeltsch H FAU - Ben Hamida, Sami AU - Ben Hamida S FAU - Riegert, Celine AU - Riegert C FAU - Kelche, Christian AU - Kelche C FAU - Jones, Byron C AU - Jones BC FAU - Cassel, Jean-Christophe AU - Cassel JC LA - eng GR - AG 21190/AG/NIA NIH HHS/United States GR - NS 35088/NS/NINDS NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Pharmacol Biochem Behav JT - Pharmacology, biochemistry, and behavior JID - 0367050 RN - 102-32-9 (3,4-Dihydroxyphenylacetic Acid) RN - 333DO1RDJY (Serotonin) RN - 54-16-0 (Hydroxyindoleacetic Acid) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - VTD58H1Z2X (Dopamine) RN - X4W3ENH1CV (Norepinephrine) SB - IM MH - 3,4-Dihydroxyphenylacetic Acid/metabolism MH - Animals MH - Body Temperature/drug effects MH - Brain/drug effects/metabolism MH - Chromatography, High Pressure Liquid MH - Dopamine/metabolism MH - Dose-Response Relationship, Drug MH - Female MH - Hydroxyindoleacetic Acid/metabolism MH - Male MH - Motor Activity/drug effects MH - N-Methyl-3,4-methylenedioxyamphetamine/*pharmacology/toxicity MH - Norepinephrine/metabolism MH - Random Allocation MH - Rats MH - Rats, Long-Evans MH - Serotonin/metabolism MH - Sex Factors MH - Sexual Maturation/*physiology MH - Survival Rate MH - Time Factors EDAT- 2005/06/14 09:00 MHDA- 2005/09/27 09:00 CRDT- 2005/06/14 09:00 PHST- 2004/06/07 00:00 [received] PHST- 2005/04/19 00:00 [revised] PHST- 2005/04/22 00:00 [accepted] PHST- 2005/06/14 09:00 [pubmed] PHST- 2005/09/27 09:00 [medline] PHST- 2005/06/14 09:00 [entrez] AID - S0091-3057(05)00165-6 [pii] AID - 10.1016/j.pbb.2005.04.014 [doi] PST - ppublish SO - Pharmacol Biochem Behav. 2005 Jul;81(3):635-44. doi: 10.1016/j.pbb.2005.04.014.